Prevention of breast cancer: current state of the science and future opportunities-Reference-Cited by-同舟云学术

Prevention of breast cancer: current state of the science and future opportunities

Published:2006-11-15 Issue:12 Volume:15 Page:1583-1600
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Uray Ivan P¹,Brown Powel H¹

Affiliation:

1. Breast Care Center, Departments of Medicine and Molecular and Cellular Biology, Baylor College of Medicine, and the Methodist Hospital, Houston, TX 77030, USA.

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.15.12.1583

Reference149 articles.

1. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

2. Empirically derived dietary patterns and risk of postmenopausal breast cancer in a large prospective cohort study

3. Understanding breast cancer risk - where do we stand in 2005?

4. Alcohol and Postmenopausal Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Prospective Cohort Study

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors;Clinical Cancer Research;2021-06-10

2. Identification of associations between small molecule drugs and miRNAs based on functional similarity;Oncotarget;2016-05-24

3. The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model;Reproductive Biology and Endocrinology;2014-07-15

4. The Influence of Energetic Factors on Biomarkers of Postmenopausal Breast Cancer Risk;Current Nutrition Reports;2013-12-15

5. Proline Primed Helix Length as a Modulator of the Nuclear Receptor–Coactivator Interaction;Journal of the American Chemical Society;2013-03-07